Fairmount Funds Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $68.8M | Hold |
|
|||||
|
2025
Q2 | $49.1M | Buy |
|
|||||
|
2025
Q1 | $24.5M | Sell |
|
|||||
|
2024
Q4 | $43.4M | Sell |
|
|||||
|
2024
Q3 | $80.1M | Hold |
|
|||||
|
2024
Q2 | $59.8M | Hold |
|
|||||
|
2024
Q1 | $63.2M | Buy |
|
|||||
|
2023
Q4 | $50.6M | Buy |
|
|||||
|
2023
Q3 | $43M | Buy |
|
|||||
|
2023
Q2 | $9.92M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $3.26M | Buy |
|
|||||
|
2020
Q2 | $5.1M | Hold |
|
|||||
|
2020
Q1 | $3.1M | Buy |
|
|||||
|
2019
Q4 | $1.83M | Buy |
|